Measles Virus Used to Kill Cancer Cells
Posted on: Tuesday, 31 October 2006, 15:00 CST
U.S. researchers are starting the second of several pending molecular medicine studies in patients using measles to kill cancer cells.
Mayo Clinic Cancer Center scientists opened the new clinical study using a vaccine strain of the measles virus to attack recurrent glioblastoma multiforme -- a largely untreatable brain tumor.
We are looking at better ways to treat some of the most lethal cancers, said Dr. Eva Galanis, oncologist and lead researcher on the glioblastoma multiforme project in the measles virus investigation. We have shown in the laboratory and in several animal models that measles virus strains can significantly shrink glioma tumors and prolong animal survival.
The Mayo Clinic says its pursuit of oncolytic measles vaccine strains for cancer treatment is unique, growing from the most basic laboratory science to a sophisticated therapy being tested in several tumor types, including glioblastoma multiforme, recurrent ovarian cancer and multiple myeloma.
The glioblastoma multiforme study, which started Tuesday, is designed to test the safety of the virus for the treatment of gliomas and enable biological monitoring of anti-tumor activity.
Source: United Press International
Related Articles
- New Device Enables Early Detection Of Cancerous Skin Tumors -- Ben Gurion U.
- Bradmer Initiates Enrollment for Phase III Glioblastoma Multiforme Trial
- Significant Tumor-Specific Immune Response Observed in AVANT's Phase 2 Trial Evaluating CDX-110 With Temozolomide for Treatment of Glioblastoma Multiforme
- Celldex Therapeutics Announces Orphan Drug Designation for CDX-110, a Novel EGFRvIII Vaccine for Glioblastoma Multiforme
- Long-Term Data From a Landmark Phase III Trial Show Survival Benefit at Three- and Four-Years in Patients With Glioblastoma Multiforme
- Novacea Initiates Phase 1/2 Trial of AQ4N in Glioblastoma Multiforme
- Adding Chloroquine to Conventional Treatment for Glioblastoma Multiforme: A Randomized, Double-Blind, Placebo-Controlled Trial
- Cleveland Clinic and UCSF Researchers Discover New Virus in Prostate Tumors
- TEMODAL(R) Approved in European Union For Treatment of Newly Diagnosed Glioblastoma Multiforme
- Glioblastoma Multiforme
 |
 |
User Comments (0)
RSS Feeds